Sirolimus RxSirolimus (rapamycin)

Sirolimus Rx / Dosing

Sirolimus Rx cost and pricing: what you actually pay

Last updated 2026-07-27

TL;DR

Generic oral sirolimus tablets typically cost $25 to $150 a month with a pharmacy discount card; brand Rapamune costs far more. Off-label compounded sirolimus for longevity dosing runs roughly $150 to $400+ monthly depending on dose, vial size, and whether a provider consult and labs are bundled in. Insurance almost never covers off-label use.

How much does sirolimus actually cost per month?

For FDA-approved use (organ transplant rejection prevention), generic oral sirolimus tablets or solution typically cost somewhere between $25 and $150 a month using a GoodRx-type discount card, depending on dose, pharmacy, and location [1]. Brand-name Rapamune, which is the same molecule, runs much higher, often several hundred dollars a month before any discount, because branded oral solid dose drugs in the U.S. carry big list-price markups over their generic equivalents regardless of therapeutic class [1]. That generic transplant-dose pricing is not the number most longevity-focused readers care about, though. People using sirolimus off-label for aging research protocols are almost always on intermittent, low-dose regimens (commonly a weekly pulse dose rather than a daily transplant dose), and they're usually getting it through a telehealth or specialty compounding channel rather than a standard retail pharmacy. That channel has its own pricing structure, and it's rarely covered by insurance at all, since the indication itself is off-label [2]. A realistic monthly range for the off-label, provider-managed route is roughly $150 to $400+, depending on whether the price includes a prescriber consult, lab work, and shipping, or is just the drug cost alone. Below we break down where that spread comes from.

Why is off-label sirolimus so much more expensive than the generic transplant drug?

Three things drive the price gap: dosing form, channel, and bundled services. First, transplant patients take daily generic tablets manufactured at large scale by companies like Zydus and Dr. Reddy's, which is what keeps retail generic pricing low [1]. Longevity protocols, by contrast, often use compounded formulations, non-standard strengths, or dosing schedules that don't match any commercially available tablet size, which pushes people toward compounding pharmacies rather than a $10 generic co-pay at CVS. Second, the off-label route usually isn't a walk-in prescription. It's a telehealth consult plus a prescription plus, often, baseline labs (lipid panel, fasting glucose, CBC) before and during use, because sirolimus can affect lipids and blood counts [3]. That consult-plus-labs bundle is where a chunk of the $150 to $400 range comes from, not the raw drug cost. Third, there's no insurance backstop. Because the FDA has approved sirolimus specifically for renal transplant rejection prophylaxis, and, in different formulations, for lymphangioleiomyomatosis (Rapamune) and PEComa (Fyarro) and facial angiofibromas in tuberous sclerosis (Hyftor topical gel), not for aging or life extension, off-label longevity use is a self-pay expense in essentially every case [3]. Insurers price and cover drugs to their approved indications; there is no CPT-coded pathway for 'longevity dosing' that a claims adjuster will pay against.

What's the difference between generic sirolimus and brand-name Rapamune pricing?

They're the same active molecule, sirolimus (rapamycin), but the brand carries a substantial price premium that has nothing to do with efficacy. Generic sirolimus has been FDA-approved and available in the U.S. since Wyeth's original patents began expiring in the 2010s, and generic manufacturers now supply the U.S. market at a fraction of brand cost [1]. If your provider writes a prescription for 'sirolimus' and your pharmacy fills generic, you're looking at the lower end of the range. If a script is written for brand Rapamune specifically, or a pharmacy has no generic in stock, you'll pay significantly more, sometimes multiples of the generic cash price. There's no clinical reason a longevity user would need brand over generic; ask your prescriber to specify generic on the script.

Sirolimus monthly cost by channel (approximate US ranges) Retail generic vs. brand vs. off-label provider-managed protocol $90 Generic (retail… $500 Brand Rapamune… $275 Off-label teleh… Source: GoodRx, 2025 (sirolimus price page)

Does insurance cover sirolimus for anti-aging or longevity use?

No. Insurance in the U.S. covers drugs against their FDA-approved indications, and there is no FDA-approved indication for aging, lifespan extension, or general 'healthspan' use [3]. If you're prescribed sirolimus for kidney transplant maintenance, insurance typically covers it like any other maintenance immunosuppressant, often with a modest copay. If you're prescribed it off-label for a longevity protocol, expect to pay entirely out of pocket, and expect your insurer to reject any claim tied to that use even if the pharmacy fills it under the same NDC code. This is also why almost nobody in the longevity-dosing space bills insurance at all. The consult, the labs, and the prescription are typically priced and paid as a self-pay bundle through a telehealth or specialty provider, similar to how compounded semaglutide or testosterone clinics operate.

What drives the price difference between compounded sirolimus and standard tablets?

Compounding adds real cost. A 503A or 503B compounding pharmacy has to source active pharmaceutical ingredient, verify potency and sterility (for injectable or reconstituted forms), and often produce smaller batches than a mass generic manufacturer, all of which raises per-unit cost compared to a commercially manufactured tablet [4]. That said, most off-label longevity protocols described in the research literature and by clinicians who publish on this use oral tablets or oral solution, not an injectable, since sirolimus for the studies underlying the human interest in it (organ transplant trials, mouse lifespan work) has been an oral agent [5]. If you see a source quoting injection or reconstitution steps for sirolimus, that's typically describing peptide-adjacent or research-chemical products, not standard pharmacy-dispensed sirolimus, and readers should be cautious about that distinction. For dosing mechanics on the standard oral route, see Sirolimus Rx dosage and the Sirolimus Rx dosage calculator.

What does a typical monthly cost breakdown actually look like?

Retail generic (transplant dose, discount card)Drug only, standard daily dosing$25 to $150 [1]
Retail brand RapamuneDrug only, standard daily dosing$300 to $700+ [1]
Telehealth/provider off-label routeConsult, prescription, sometimes labs, low-dose weekly protocol$150 to $400+
Compounding pharmacy, cash payDrug only, non-standard strength or formVaries widely by dose and pharmacyThe honest takeaway: the drug itself is cheap in its generic form. What you're really paying for in the off-label longevity channel is physician oversight, monitoring, and a legitimate prescription pathway, plus the compounding premium if your dose or form isn't a standard commercial tablet.

Here's a rough comparison across the channels people actually use. These are directional ranges, not quotes, since pharmacy pricing varies by state, dose, and discount program. | Channel | What's included | Typical monthly cost |

Are there cheaper ways to get sirolimus, and are they safe?

Yes, there are cheaper routes, and no, we wouldn't recommend the cheapest ones. Some people buy 'research chemical' rapamycin from gray-market vendors with no prescription, no quality control, and no physician oversight, at prices sometimes well below even generic pharmacy cost. That's a real risk, not a bargain, because you have no assurance of actual potency, sterility, or even correct identity of what's in the vial, and no clinician checking your lipid panel or watching for early signs of immunosuppression-related infection. Sirolimus meaningfully suppresses immune function even at low, intermittent doses, since that's the mechanism it shares with its FDA-approved transplant indication . It can also cause mouth ulcers (stomatitis), which is one of the most commonly reported side effects in clinical trials of the drug , and can raise triglycerides and cholesterol or worsen glucose control in some users [3] . None of that changes because you bought it cheaper from an unregulated source. A provider-reviewed prescription, filled through a licensed pharmacy, is the only route that gives you a real chance at catching those effects before they become a problem.

Why doesn't a longevity dose have solid pricing data the way transplant dosing does?

Because there is no approved longevity indication and no completed human lifespan trial to anchor it to. The strongest evidence for rapamycin extending lifespan comes from mice, specifically the National Institute on Aging's Interventions Testing Program (ITP), which has repeatedly found that rapamycin extends median lifespan in genetically heterogeneous mice, in some cohorts even when started relatively late in life . The ITP's own reporting states that rapamycin remains one of the few compounds tested across its multi-site protocol to show a consistent, reproducible mouse lifespan extension effect . But mice are not humans, and nobody has run the human trial that would establish what dose, schedule, and duration extend human healthspan or lifespan, at what cost, with what monitoring burden. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), a community-funded study out of AgelessRx, looked at low-dose rapamycin in healthy older adults over roughly 48 weeks and reported some improvements in patient-reported outcomes, but it was not designed or powered to measure lifespan and had real limitations around blinding and endpoints . Until a properly powered human trial with hard endpoints exists, every price quoted for a 'longevity protocol' is really a price for an off-label prescription of an approved immunosuppressant, not a price for a proven lifespan intervention.

What should you budget for before starting, beyond the drug cost itself?

Budget for labs, more than pills. A responsible off-label protocol includes baseline and periodic bloodwork, at minimum a lipid panel, fasting glucose or HbA1c, and a CBC, because sirolimus is known to affect lipid metabolism, glucose handling, and blood counts even at low, intermittent doses used in longevity protocols [3] . Some telehealth providers bundle this into a flat monthly or quarterly fee; others bill labs separately through a service like Quest or Labcorp, which can run another $50 to $200 out of pocket if not covered by insurance. Budget for follow-up visits too. A provider adjusting your dose or checking in on side effects (mouth ulcers, GI symptoms, unusual infections) should be part of what you're paying for, not an afterthought. If a source is selling you sirolimus with zero lab requirement and zero follow-up, that's a red flag regardless of price. Sirolimus Rx's provider-reviewed model, fulfilled through a licensed pharmacy partner, is built around exactly this: a real prescriber reviewing your case and labs before and during use, more than a checkout page.

How does dosing schedule change what you actually spend?

Most off-label longevity protocols use an intermittent schedule (commonly once weekly) rather than the daily dosing used in transplant medicine, and that schedule directly affects your monthly pill or vial count and therefore your cost. A once-weekly protocol at a given strength uses roughly one-seventh the tablets of a daily protocol at the same strength, which can meaningfully lower monthly drug spend even before considering dose differences. The tradeoff is that dosing intervals in the off-label longevity literature are not standardized. Reported human protocols (including the dosing structure used in the PEARL study) vary in both dose and interval, and there's no consensus clinical guideline for 'the' longevity dose the way there is an approved package insert dose for transplant use . If you're comparing prices between two providers, make sure you're comparing the same weekly dose and cycle length, more than the same monthly fee, since a lower monthly price on a higher dose isn't actually cheaper per milligram. See Sirolimus Rx cycle length for how cycle structure is typically described.

Is sirolimus and rapamycin pricing the same thing, or are they priced differently?

Sirolimus and rapamycin are the same molecule; rapamycin is the original name (from Rapa Nui, Easter Island, where the soil bacterium producing it was discovered), and sirolimus is the pharmaceutical generic name used on prescriptions and packaging in the U.S. . You won't find two different price lists for 'rapamycin' versus 'sirolimus' at a licensed U.S. pharmacy; a prescription written for either name should resolve to the same generic product unless a compounding pharmacy is using a specific sourced active ingredient it labels differently. If a vendor is pricing 'rapamycin' separately from 'sirolimus' and implying they're different or that one is a superior version, that's a marketing distinction, not a pharmacological one.

Frequently asked questions

How much does sirolimus cost per month without insurance?

Generic oral sirolimus at standard transplant dosing typically costs $25 to $150 a month with a discount card at retail pharmacies [1]. Off-label, provider-managed longevity protocols usually run higher, roughly $150 to $400+ a month, because that price often bundles a consult and periodic labs rather than just the drug itself.

Is Rapamune more expensive than generic sirolimus?

Yes, substantially. Brand-name Rapamune can cost several hundred dollars a month or more before discounts, while the generic version of the same molecule typically costs a fraction of that at retail pharmacies [1]. There's no clinical reason to choose brand over generic; ask your prescriber to specify generic sirolimus on the script.

Does insurance ever cover sirolimus for longevity use?

No. Sirolimus is FDA-approved for organ transplant rejection prevention, and in other formulations for lymphangioleiomyomatosis, PEComa, and tuberous sclerosis-related skin lesions, not for aging or lifespan extension [4]. Insurers cover drugs against approved indications, so off-label longevity use is essentially always a self-pay expense.

Why is off-label sirolimus more expensive than the transplant version?

It usually involves a telehealth consult, a prescription for a non-standard schedule, and lab monitoring bundled into the price, more than the pill cost. Compounded or non-standard-strength formulations also cost more per unit than mass-produced generic tablets, which is where much of the price gap comes from.

What labs should be included in the cost of a sirolimus protocol?

At minimum, expect a lipid panel, fasting glucose or HbA1c, and a complete blood count before starting and periodically during use, since sirolimus can affect cholesterol, triglycerides, glucose control, and blood counts [3][7]. If a provider offers sirolimus with no lab requirement at any price, treat that as a warning sign.

Is cheap 'research chemical' rapamycin from overseas vendors a good deal?

No. It may look cheaper up front, but you get no assurance of potency, purity, or even correct identity, and no physician monitoring your bloodwork or checking for immunosuppression-related risks. Given that sirolimus meaningfully suppresses immune function even at low doses, that's not a place to cut cost [7].

Are sirolimus and rapamycin priced or sold differently?

No, they're the same molecule. Rapamycin is the original scientific name and sirolimus is the pharmaceutical generic name used on U.S. prescriptions [10]. A licensed pharmacy shouldn't have two separate price lists for them; if a vendor implies otherwise, that's marketing framing, not a real pharmacological difference.

Has any human trial shown rapamycin extends lifespan, justifying the cost?

No completed human trial has demonstrated lifespan extension from rapamycin. The strongest evidence is from mice via the NIA's Interventions Testing Program, which has repeatedly shown lifespan extension across multiple cohorts [8]. The human PEARL trial measured patient-reported outcomes over about 48 weeks, not lifespan, and had real design limitations [9].

What side effects should you weigh against the cost of a longevity protocol?

Mouth ulcers (stomatitis) are among the most commonly reported side effects in sirolimus trials, and the drug can raise triglycerides and cholesterol or worsen glucose control in some users [3][7]. Because it's an immunosuppressant, it also raises infection risk, even in low, intermittent longevity dosing schedules; this is the real tradeoff, more than the price tag.

Does a higher price mean a better or safer sirolimus protocol?

Not necessarily. Price differences mostly reflect whether you're paying for consult time, lab monitoring, and follow-up, versus just the raw drug. A cheaper option that skips labs and physician oversight is a worse deal even at a lower price, and an expensive option isn't automatically better if it's not actually including monitoring.

How does dosing schedule affect what you pay each month?

Most off-label protocols use once-weekly or other intermittent dosing rather than daily transplant dosing, which uses far fewer tablets per month and can lower drug cost even at similar per-pill strength. Compare providers by weekly dose and cycle length, more than the flat monthly price, since protocols vary [9].

Where can you get a legitimate prescription for off-label sirolimus rather than buying it unregulated?

Through a licensed telehealth or in-person provider who reviews your history and labs before prescribing, with the prescription filled at a licensed pharmacy. Sirolimus Rx's provider-reviewed model works this way, connecting patients to a prescriber and a fulfilling pharmacy partner rather than shipping product with no clinical oversight.

Sources

  1. GoodRx, Sirolimus price and coupon page: Generic sirolimus and brand Rapamune retail pricing ranges
  2. FDA, Human Drug Compounding under Sections 503A and 503B: Basis for cost differences between compounded and commercially manufactured drug products
  3. National Institute on Aging, Interventions Testing Program overview: Rapamycin studied as an oral agent in the ITP mouse lifespan program
  4. Green et al., PEARL trial, Aging Cell / medRxiv preprint on rapamycin in healthy adults: PEARL trial design, duration, and patient-reported outcome findings for low-dose rapamycin in humans
  5. National Institutes of Health, National Cancer Institute Drug Dictionary, sirolimus entry: Sirolimus and rapamycin refer to the same molecule